Life Sciences Tools and Services

Bionano Genomics

Bionano Genomics released FY2026 Q1 earnings on May 13 During-Market EST, actual revenue USD 6.687 M (forecast USD 6.568 M), actual EPS USD -0.76 (forecast USD -0.88)

Bionano Genomics to Release FY2026 Q1 Earnings on May 13 During-Market EST, Forecast Revenue USD 6.568 M, EPS USD -0.88

Bionano Genomics released FY2025 Q4 earnings on March 23 After-Market EST, actual revenue USD 7.951 M (forecast USD 7.88 M), actual EPS USD -0.7707 (forecast USD -0.81)

Bionano Genomics released FY2025 earnings on March 23 After-Market EST, actual revenue USD 28.51 M (forecast USD 28.44 M), actual EPS USD -4.85 (forecast USD -6.395)

Bionano Genomics to Release FY2025 Q4 Earnings on March 23, 2026 After-Market EST, Forecast Revenue USD 7.88 M, EPS USD -0.81

Maxim Group Analyst Gives Buy Rating to BioNano Genomics

Bionano Genomics released FY2025 9 Months Earnings on November 13 After-Market EST, with actual revenue of USD 20.56 M and EPS of USD -4.737

Bionano Genomics released FY2025 Q3 earnings on November 13 After-Market EST, actual revenue USD 7.367 M (forecast USD 6.906 M), actual EPS USD -1.5929 (forecast USD -2.075)

Bionano Genomics to Release FY2025 Q3 Earnings on November 13 After-Market EST, Forecast Revenue USD 6.906 M, EPS USD -2.075

Bionano Genomics released FY2025 Semi-Annual Earnings on August 14 After-Market EST, with actual revenue of USD 13.19 M and EPS of USD -3.2436

Bionano Genomics released FY2025 Q2 earnings on August 14 After-Market EST, actual revenue USD 6.733 M (forecast USD 6.564 M), actual EPS USD -1.9927 (forecast USD -2.6666)

Bionano Genomics to release FY2025 Q2 earnings on August 14 After-Market EST, forecast revenue USD 6.898 M, EPS USD -2.6466

Bionano Genomics Participates in ESHG to Showcase OGM Technology

Bionano Genomics Holds 2025 Annual Shareholders' Meeting

Maxim Group Upgrades Bionano Genomics to Buy

Bionano Genomics Rated as Outperform with a Target Price of $7

Bionano Genomics released FY2025 Q1 earnings on May 14 After-Market EST, actual revenue USD 6.457 M (forecast USD 6.25 M), actual EPS USD -1.1514 (forecast USD -3.0233)

Bionano Genomics Reports Q1 Revenue of $6.5 Million

Bionano Genomics Inc to Report a Quarterly Loss of $3.02 per Share in Q1 2025

Bionano Genomics to release FY2025 Q1 earnings on May 14 After-Market EST, forecast revenue USD 6.25 M, EPS USD -3.0233

Akanda

Agape ATP

Co-Diagnostics

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NewGenIvf

Tradr 2X Long QBTS Daily ETF

Tradr 2X Long RGTI Daily ETF

Defiance Daily Target 2X Long RGTI ETF

Liminatus Pharma

LAFAYETTE ACQUISITION CORP ORD USD0.0001(S/R)24/10/2030

BNGO

LABU

SBIO

Bionano Genomics (NASDAQ:BNGO) reported Q1 2026 revenue of $6.7 million, a 4% year-over-year increase, with flow cell sales up 17%. The company highlighted strategic pillars focused on supporting its installed base, increasing Optical Genome Mapping (OGM) utilization, securing reimbursement, and improving profitability. Key milestones include a 47% increase in reimbursement rates for OGM and a new CPT code for genetic disorders. Gross margin improved to 49%, and the company aims for cash flow breakeven by Q4 2027, driven by strong demand and reduced debt.

Fidelity

Proshares Ultra Nasdaq Biotech

iShares US Medical Devices

First Trust NYSE Arca Biotech Index Fd

Direxion S&P Biotech Bull 3X

Invesco Biotechnology & Genome ETF

SPDR S&P Biotech

ALPS Medical Breakthrough

iShares Biotechnology ETF

VanEck Biotech ETF

Transcript: Bionano Genomics Q1 2026 Earnings Conference Call

Earnings Watch

Bionano Genomics | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 6.687 M

Bionano Genomics | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 6.687 M

CSCL

U.S. stock futures were mixed as investors awaited inflation data following a hotter-than-expected consumer inflation report. The S&P 500 and Nasdaq saw slight gains, while Dow futures dipped. Brent crude prices fell slightly, and markets reacted to President Trump's criticism of the U.S.-Iran ceasefire. European stocks rose, and Asia-Pacific markets also gained, influenced by the U.S. inflation data. Key earnings reports from BioNano Genomics and Cisco are expected, alongside the producer price index report.

Tip Ranks

Direxion Daily CSCO Bull 2X Shares

S&P 500

NASDAQ-100

Invesco QQQ Trust

NASDAQ Composite Index

Dow Jones Industrial Average

Cisco

Hang Seng Index

SSE Index

Shenzhen Index

Stock Market News, 5/13/26 – U.S Stock Futures Mixed Ahead of Inflation Data amid Middle East Uncertainty

09988

NBIS

BABA

KBAB

BABX

U.S. stock futures were flat on May 12, 2026, as investors awaited a key inflation report following a hotter-than-expected consumer inflation report. Futures for the Dow, Nasdaq, and S&P 500 were down slightly. In regular trading, the S&P 500 and Nasdaq fell after April core inflation exceeded expectations, while oil prices continued to rise. Earnings reports from Alibaba, Nebius, BioNano Genomics, and Cisco are expected on Wednesday, alongside key economic reports like the producer price index (PPI).

- U.S. stock futures remained flat as investors anticipated a key inflation report following a higher-than-expected consumer inflation data.  
- The Dow Jones Industrial Average, Nasdaq 100, and S&P 500 futures saw marginal declines of 0.01%, 0.02%, and 0.04%, respectively.  
- Major companies, including Alibaba and Cisco, are expected to report earnings, while traders are also focused on the upcoming producer price index report.

BABA-W

Nebius

Alibaba

KraneShares 2x Long BABA Daily ETF

BABA 2x Long Daily ETF - GraniteShares

BABA-WR

Alibaba HK SDR 5to1

Why Are Stock Market Futures Flat Today, 5/12/26?

ATER

ATER (Aterian, Inc.) is set to announce its Q1'26 results on May 12, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q1'26, revenue estimate is 15.82 million USD with EPS (earnings per share) anticipated at (0.69) USD. Learn more details at .Revenue & EPS values are provided in USDQ1'25Q2'25Q3'25Q4'25Q1'26Revenue Reported15.36 M19.46 M19.02 M——Revenue Estimate14.95 M20.37 M19.88 M18.38 M15.82 MRevenue Surprise+2.74%-4.45%-4.31%EPS Reported(0.52)(0.63)(0.28) EPS Estimate(0.69)(0.54)(0.63)(0.58)(0.69) EPS Surprise+24.64%-16.67%+55.56%DisclaimerSelect reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

TradingView

Aterian

Factset Research

ATER Q1'26 Earnings: EPS estimate is (0.69) USD